The NIH's Zika vaccine will move into phase 2 testing, officials said Friday. Despite the president's threats of spending cuts, this project is fully…
A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.
The U.S. government is pumping more money into anthrax bioterror preparedness.
Protein Sciences will start the search for two new H7N9 vaccine candidates by request of the HHS’ Biomedical Advanced Research and Development Authority.
A new Zika vaccine candidate by GeoVax showed promise in preclinical tests on mice, and the company touts it as “the best solution” to the disease.
Sen. Sanders blasted a proposed Zika license, saying Americans shouldn't have to "pay the highest price in the world for a vaccine we paid to help…
Roche has teamed up to test its immuno-oncology med Tecentriq with Bavarian Nordic's CV301, the same vaccine BMS is testing in combination with Opdivo.
The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.
Novavax isn’t letting a bruising phase 3 failure for its RSV vaccine kill its enthusiasm around the program.
Inovio’s Zika and MERS vaccine candidates, both the first to undergo human testing in those diseases, turned in some positive early data.